Deerfield Private Design Fund V, L.P. — SEC Form 4 filings

SEC reporting owner CIK 1815437. 6 Form 4 filings on record with FilingPulse; latest filed 2025-04-23.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-19 to 2025-04-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Bicara Therapeutics Inc. (BCAX)10% owner12 legs · 70,000 sh · $1,260,0004
BiomX Inc. (PHGE)Director522

Form 4 filings — Deerfield Private Design Fund V, L.P.

FiledFormIssuerReported transactionsSource
2025-04-234BiomX Inc. (PHGE)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund II, L.P.
Grant/award (A): 1,611,864 (derivative) · Grant/award (A): 1,611,864 (derivative)EDGAR
2025-03-034BiomX Inc. (PHGE)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund II, L.P.
Option exercise (M): 353,249 @ $0.93 · Option exercise (M): 353,249 @ $0.93 · Option exercise (M): 1,611,863 (derivative) · Option exercise (M): 1,611,863 (derivative) · Grant/award (A): 1,258,614 (derivative) · Grant/award (A): 1,258,614 (derivative)EDGAR
2024-09-174Bicara Therapeutics Inc. (BCAX)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., DEERFIELD PARTNERS, L.P., Deerfield Mgmt L.P.
Conversion (C): 862,587 · Conversion (C): 862,587 · Purchase (P): 35,000 @ $18 · Purchase (P): 35,000 @ $18 · Conversion (C): 7,973,325 (derivative) · Conversion (C): 7,973,325 (derivative)EDGAR
2024-07-174BiomX Inc. (PHGE)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund II, L.P.
Option exercise (M): 5,883,000 · Option exercise (M): 5,883,000 · Option exercise (M): 5,883 (derivative) · Option exercise (M): 5,883 (derivative)EDGAR
2024-07-114BiomX Inc. (PHGE)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund II, L.P.
Grant/award (A): 722,175 (derivative) · Grant/award (A): 722,175 (derivative) · Grant/award (A): 20,175,000 (derivative) · Grant/award (A): 20,175,000 (derivative)EDGAR
2024-03-194BiomX Inc. (PHGE)
jointly with Flynn James E, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deerfield Mgmt V, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund II, L.P.
Grant/award (A): 3,055,049 · Grant/award (A): 3,055,049 · Grant/award (A): 13,490 (derivative) · Grant/award (A): 13,490 (derivative) · Grant/award (A): 40,350 (derivative) · Grant/award (A): 40,350 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1815437 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →